Apolipoprotein E (apoE) and its three major alleles (APOE2, E3, and E4) have been implicated in Alzheimer's disease and other neurological disorders. Little is known of the role apoE plays in normal brain function and pathology. To create a model to study apoE in brain, we have generated APOE transgenic mice using microinjection of allele-specific human genomic fragments to establish founders which were then bred to APOE knockout mice lacking a functional mouse apoE protein. This allows the study of apoE without interference from the endogenous mouse APOE gene. Results demonstrate that transgenic lines have been established that transcribe and express apoE appropriately in brain, liver, and other tissues. High cholesterol levels found in APOE knockout mice are substantially corrected in the APOE transgenic lines. ApoE immunoreactivity has been detected in glial cells and selected classes of neurons in all three isoform-specific transgenics. This pattern of immunoreactivity is similar to that observed in nonhuman primates and man, and contrasts with the strictly glial staining pattern of normal rodents. r
INTRODUCTION
The three major isoforms of human apolipoprotein E are associated with differences in the age of onset distribution of Alzheimer's disease (AD) (Strittmatter et al., 1993; Saunders et al., 1993a,b) . Apolipoprotein E (APOE, gene; apoE, protein) is encoded by four exons, 3597 nucleotides in length, on the long arm of human chromosome 19. The mature form of apoE in plasma and cerebrospinal fluid contains 299 amino acids coded by a 1163-nucleotide mRNA (Mahley, 1988) . The three major alleles of APOE are named E2, E3, and E4 with allele frequencies of approximately 7, 78, and 15%, respectively. These three isoforms differ by a single unit of net charge and can be separated by isoelectric focusing (Utermann et al., 1979) . The most common isoform, E3, is characterized by the presence of a cysteine residue at amino acid position 112 and an arginine residue at position 158. The two less common isoforms, E2 and E4, each differ from the E3 form by the substitution of a single amino acid (Mahley, 1988) . E4 contains an arginine at residue 112 while E2 contains a cysteine at residue 158. The E4 isoform is more positively charged than E3 and E2 and lacks sulfhydryl groups at these sites. Functionally, the E2 isoform has a lower affinity for the LDL receptor than does E3 and
